EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The Efficacy and Safety of Botulinum Toxin Type A in Prevention of Hypertrophic Scars After Epicanthoplasty: A Split-Face Double-Blinded Randomized Controlled Trial

Dandan Liu, Yanting Ou, Lin Luo, Mengfan Wu, Yihan Zhang, Luotai Chen, Zhuolin Liu, Tingyin Lin, Xiangwen Xu, Yongyan Cui iD

Aesthetic Plastic Surgery · 2025-03 · 49 (5) · 1227-1238

DOI: 10.1007/s00266-024-04498-w ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 16.12.2024. Verfasst von Dandan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Cicatrix, Hypertrophic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Natural Science Foundation from Shenzhen Science and Technology Innovation Commission, Shenzhen Key Medical Discipline Construction Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ACicatrix, HypertrophicHumansFemaleMaleDouble-Blind MethodTreatment OutcomeAdolescentFollow-Up StudiesYoung AdultAdultEstheticsRisk AssessmentNeuromuscular Agents

Stichwörter der Autor:innen

Botulinum toxin type AEpicanthoplastyHypertrophic scarRCT

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China.
  • Department of Plastic Surgery, Shenzhen Xinhua Hospital, Shenzhen, 518131, Guangdong, China.
  • Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China. drxuxiangwen@163.com.
  • Department of Plastic Surgery, Shenzhen Xinhua Hospital, Shenzhen, 518131, Guangdong, China. drxuxiangwen@163.com.
  • Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, Guangdong, China. cyy8188@163.com.

ORCID-Profile: Yongyan Cui

Förderung

  • National Nature Science Foundation of China
  • Natural Science Foundation from Shenzhen Science and Technology Innovation Commission
  • Shenzhen Key Medical Discipline Construction Fund
  • Peking University Shenzhen Hospital Research Project Fund
  • Guangdong Medical Science and Technology Research Foundation

Zitieren

APA

Liu, D., Ou, Y., Luo, L., Wu, M., Zhang, Y., Chen, L., Liu, Z., Lin, T., Xu, X., & Cui, Y. (2025). The Efficacy and Safety of Botulinum Toxin Type A in Prevention of Hypertrophic Scars After Epicanthoplasty: A Split-Face Double-Blinded Randomized Controlled Trial. Aesthetic Plastic Surgery, 49(5), 1227-1238. https://doi.org/10.1007/s00266-024-04498-w

Vancouver

Liu D, Ou Y, Luo L, Wu M, Zhang Y, Chen L, et al. The Efficacy and Safety of Botulinum Toxin Type A in Prevention of Hypertrophic Scars After Epicanthoplasty: A Split-Face Double-Blinded Randomized Controlled Trial. Aesthetic Plastic Surgery. 2025;49(5):1227-1238. doi:10.1007/s00266-024-04498-w

BibTeX
@article{Liu2025,
  author = {Liu, Dandan and Ou, Yanting and Luo, Lin and Wu, Mengfan and Zhang, Yihan and Chen, Luotai and Liu, Zhuolin and Lin, Tingyin and Xu, Xiangwen and Cui, Yongyan},
  title = {The Efficacy and Safety of Botulinum Toxin Type A in Prevention of Hypertrophic Scars After Epicanthoplasty: A Split-Face Double-Blinded Randomized Controlled Trial},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  volume = {49},
  number = {5},
  pages = {1227--1238},
  doi = {10.1007/s00266-024-04498-w}
}
Kostenlos starten →